Lilly Ventures-backed startup grabs $4.6M round

A secretive startup at Lilly Ventures in Indianapolis has grabbed $4.6 million of a documented $15 million round of equity financing, MedCity News reported, citing SEC documents. The recently founded Esanex doesn't appear to have a website or a publicly known research focus, but the startup does appear to have resources from drug giant Eli Lilly's ($LLY) $200 million venture unit. According to MedCity News, Lilly Ventures partner Steven Hall is identified as the young company's chief executive. Report

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.